Outcomes of small for gestational age infants born at <27 weeks' gestation
- PMID: 23415614
- PMCID: PMC3947828
- DOI: 10.1016/j.jpeds.2012.12.097
Outcomes of small for gestational age infants born at <27 weeks' gestation
Abstract
Objective: To determine whether small for gestational age (SGA) infants born at <27 weeks gestational age (GA) are at increased risk for mortality, morbidity, and growth and neurodevelopmental impairment at 18-22 months corrected age.
Study design: This was a retrospective cohort study from National Institute of Child Health and Human Development Neonatal Research Network's Generic Database and Follow-Up Studies. Infants born at <27 weeks GA between January 2006 and July 2008 were included. SGA was defined as birth weight <10th percentile for GA based on Olsen growth curves. Infants with birth weight ≥ 10th percentile for GA were classified as non-SGA. Maternal and infant characteristics, neonatal outcomes, and neurodevelopmental data were compared in SGA and non-SGA infants. Neurodevelopmental impairment was defined as any of the following: cognitive score <70 on the Bayley Scales of Infant Development III, moderate or severe cerebral palsy, bilateral hearing loss (with and without amplification), or blindness (bilateral vision <20/200). Logistic regression analysis was applied to evaluate the associations between SGA status and death or neurodevelopmental impairment.
Results: The SGA group comprised 385 infants; the non-SGA group, 2586 infants. Compared with mothers of non-SGA infants, mothers of SGA infants were more likely to have a high school education, prenatal care, cesarean delivery, pregnancy-induced hypertension, and antenatal corticosteroid exposure. Compared with non-SGA infants, SGA infants had higher mortality and were more likely to have postnatal growth failure, prolonged mechanical ventilation, and postnatal steroid use. SGA status was associated with increased risk of death or neurodevelopmental impairment (OR, 3.91; 95% CI, 2.91-5.25; P < .001).
Conclusion: SGA status in infants born at <27 weeks GA is associated with an increased likelihood of postnatal steroid use, mortality, growth failure, and neurodevelopmental impairment at 18-22 months corrected age.
Copyright © 2013. Published by Mosby, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Kamoji VM, Dorling JS, Manktelow BN, Draper ES, Field DJ. Extremely growth-retarded infants: is there a viability centile? Pediatrics. 2006;118:758–63. - PubMed
-
- Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol. 2000;182:198–206. - PubMed
Publication types
MeSH terms
Grants and funding
- U10 HD27851/HD/NICHD NIH HHS/United States
- U10 HD027856/HD/NICHD NIH HHS/United States
- U10 HD021364/HD/NICHD NIH HHS/United States
- U10 HD40521/HD/NICHD NIH HHS/United States
- U10 HD53109/HD/NICHD NIH HHS/United States
- U10HD27880/HD/NICHD NIH HHS/United States
- U10 HD27856/HD/NICHD NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 TR000041/TR/NCATS NIH HHS/United States
- U10HD53119/HD/NICHD NIH HHS/United States
- UL1 RR24160/RR/NCRR NIH HHS/United States
- M01 RR32/RR/NCRR NIH HHS/United States
- U10 HD021385/HD/NICHD NIH HHS/United States
- M01 RR44/RR/NCRR NIH HHS/United States
- U10 HD40492/HD/NICHD NIH HHS/United States
- M01 RR59/RR/NCRR NIH HHS/United States
- U10 HD21364/HD/NICHD NIH HHS/United States
- U10 HD34216/HD/NICHD NIH HHS/United States
- M01 RR70/RR/NCRR NIH HHS/United States
- U10 HD36790/HD/NICHD NIH HHS/United States
- U10 HD053109/HD/NICHD NIH HHS/United States
- UL1 TR001449/TR/NCATS NIH HHS/United States
- U10 HD27904/HD/NICHD NIH HHS/United States
- U10 HD040461/HD/NICHD NIH HHS/United States
- U10 HD53089/HD/NICHD NIH HHS/United States
- U10 HD27853/HD/NICHD NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- M01 RR39/RR/NCRR NIH HHS/United States
- M01 RR30/RR/NCRR NIH HHS/United States
- M01 RR80/RR/NCRR NIH HHS/United States
- M01 RR16587/RR/NCRR NIH HHS/United States
- M01 RR8084/RR/NCRR NIH HHS/United States
- M01 RR54/RR/NCRR NIH HHS/United States
- M01 RR997/RR/NCRR NIH HHS/United States
- U10 HD21373/HD/NICHD NIH HHS/United States
- U10HD21397/HD/NICHD NIH HHS/United States
- UG1 HD053109/HD/NICHD NIH HHS/United States
- M01 RR750/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
